Expression of Ret/PTC in German Papillary Thyroid Carcinoma
Author Information
Author(s): B Mayr, E Potter, P Goretzki, J Ruschoff, W Dietmaier, C Hoang-Vu, H Dralle, G Brabant
Primary Institution: Medizinische Hochschule Hannover
Hypothesis
What is the expression frequency of ret/PTC oncogene in German papillary thyroid carcinomas?
Conclusion
The study found that 8% of the examined German papillary thyroid carcinomas expressed the ret/PTC oncogene, but none showed the newly described variants.
Supporting Evidence
- Eight ret/PTC-positive tumors were identified in the study.
- The study examined 99 papillary thyroid carcinomas from various German institutions.
- Previous studies reported a variable prevalence of ret/PTC from 2.5% to 30%.
Takeaway
The researchers looked at thyroid cancer samples and found that a small number had a specific gene change, but none had the new types of changes that were recently discovered.
Methodology
Tissue specimens were homogenized, RNA was extracted, and PCR was used to detect ret/PTC expression.
Limitations
The presence of ret/PTC2 cannot be excluded due to lack of a positive control.
Participant Demographics
German patients with papillary thyroid carcinoma.
Want to read the original?
Access the complete publication on the publisher's website